Meperidine-D4.HCl (Pethidine-D4.HCl)
- CAS No.
- 2748469-74-9
- Chemical Name:
- Meperidine-D4.HCl (Pethidine-D4.HCl)
- Synonyms
- Meperidine-D4.HCl (Pethidine-D4.HCl);ethyl 3,3,5,5-tetradeuterio-1-methyl-4-phenylpiperidine-4-carboxylate;Meperidine-D4.HCl (Pethidine-D4.HCl), 1mg/ml in Methanol (as free base);Meperidine-D4.HCl (Pethidine-D4.HCl), 0.1mg/ml in Methanol (as free base);1-methyl-4-phenyl-4-piperidine-d4-carboxylicacid,ethylester,monohydrochloride
- CBNumber:
- CB412867093
- Molecular Formula:
- C15H17D4NO2.ClH
- Molecular Weight:
- 287.82
- MDL Number:
- MOL File:
- 2748469-74-9.mol
- MSDS File:
- SDS
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() ![]() ![]() GHS02,GHS06,GHS08 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H225-H301+H311+H331-H370 | |||||||||
| Precautionary statements | P210-P240-P241-P242-P243-P260-P264-P270-P271-P280-P301+P310-P321-P330-P303+P361+P353-P304+P340-P307+P311-P312-P361+P364-P370+P378-P403+P233-P403+P235-P405-P501 | |||||||||
| NFPA 704 |
|
Meperidine-D4.HCl (Pethidine-D4.HCl) price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 21323 | Meperidine-d4 (hydrochloride) (CRM) | 2748469-74-9 | 1mg | $131 | 2026-04-30 | Buy |
| Cayman Chemical | 18561 | Meperidine-d4 (hydrochloride) ≥98% | 2748469-74-9 | 1mg | $131 | 2026-04-30 | Buy |
| Cayman Chemical | 21323 | Meperidine-d4 (hydrochloride) (CRM) | 2748469-74-9 | 1 mg | $119 | 2024-03-01 | Buy |
| Cayman Chemical | 18561 | Meperidine-d4 (hydrochloride) ≥98% | 2748469-74-9 | 1 mg | $119 | 2024-03-01 | Buy |
| aablocks | AA01EPP2 | Meperidine-d4 (hydrochloride) ≥98% | 2748469-74-9 | 1mg | $131 | 2026-05-30 | Buy |
Meperidine-D4.HCl (Pethidine-D4.HCl) Chemical Properties, Uses, Production
Description
Meperidine-d4 (hydrochloride) (CRM) is a certified reference material intended for use as an internal standard for the quantification of meperidine by GC- or LC-MS. Meperidine is categorized as an opioid.1 It is an opioid analgesic that is commonly abused.2 Meperidine is regulated as a Schedule II compound in the United States. Meperidine-d4 (hydrochloride) (CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
References
1. Ossipov, M.H., Harris, S., Lloyd, P., et al. Antinociceptive interaction between opioids and medetomidine: Systemic additivity and spinal synergy Anesthesiology 73(6),1227-1235(1990).
2. Atluri, S.A., Sudarshan, G., and Manchikanti, L. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011 Pain Physician 17(2),E119-E128(2014).







